PharmaCyte Biotech Inc (PMCB)

[Cures Illuminate]

Back To Witness PMCB Better Than Ever Bringing the Ball Across the IND FDA Goal Line For Approval and Beyond!

Selection of proven Dr. Jose Iglesias is a big win to quarterback the team with Legendary coach Dr. Manuel Hidalgo as the Principal Investigator for Clinical Trial in Pancreatic Cancer

“Dr. Hidalgo is a leading authority in oncology who has special expertise in pancreatic cancer and will be vital in our efforts to further elevate the cancer enterprise at Weill Cornell Medicine and NewYork-Presbyterian,” said Dr. Peter Schlegel

https://news.weill.cornell.edu/news/2019/03/dr-manuel-hidalgo-named-chief-of-the-division-of-hematology-and-medical-oncology-at


Dr. Jose Iglesias is know to attract investors:
Check out this link for current Dr. Jose Iglesias CMO position count NEA, 8VC, Amgen Ventures, Lux Capital, Menlo Ventures, Pear Ventures, Allen & Company, Nest.Bio, Omega Funds, and LifeForce Capital among its investors.

https://www.businesswire.com/news/home/20200303005309/en/Senti-Biosciences-Announces-Dr.-Jose-Iglesias-Chief


Who is investing in Pancreatic Cancer Research?
Exciting News: $15 Million Proposed for Pancreatic Cancer Research Program at the Department of Defense
https://www.pancan.org/news/exciting-news-15-million-proposed-for-pancreatic-cancer-research-program-at-the-department-of-defense/

Since 2003, PanCAN, working in partnership with generous donors, has invested approximately $126 million, including our competitive Research Grants Program and leading-edge scientific and clinical initiatives
https://www.pancan.org/research/increasing-pancreatic-cancer-research-funding/

Funding Sources list
https://www.pancan.org/research/resources-for-scientists/funding-sources/


When IND approved by FDA there will be ample funders for PMCB!!!